Fertility: Fertility studies have not been performed.
Cisatracurium (Nimbex) should be used during pregnancy only if the expected benefit to the mother outweighs any potential risk to the foetus.
Teratogenecity: Animal studies have indicated that cisatracurium has no adverse effects on foetal development.
Use in Lactation: It is not known whether cisatracurium or its metabolites are excreted in human milk.